Godrej Consumer Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:10 am

Competitors of Godrej Consumer Products Ltd

All Competitor Stocks of Godrej Consumer Products Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:15 am

Below is a detailed analysis of the quarterly data for Godrej Consumer Products Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,662.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,598.00 Cr. (Mar 2025) to 3,662.00 Cr., marking an increase of 64.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,967.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,839.00 Cr. (Mar 2025) to 2,967.00 Cr., marking an increase of 128.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 695.00 Cr.. The value appears to be declining and may need further review. It has decreased from 759.00 Cr. (Mar 2025) to 695.00 Cr., marking a decrease of 64.00 Cr..
• For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 19.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 23.00 Cr..
• For Interest, as of Jun 2025, the value is 86.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 90.00 Cr. (Mar 2025) to 86.00 Cr., marking a decrease of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 59.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 73.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 14.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 614.00 Cr.. The value appears to be declining and may need further review. It has decreased from 639.00 Cr. (Mar 2025) to 614.00 Cr., marking a decrease of 25.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 36.00% (Mar 2025) to 26.00%, marking a decrease of 10.00%.
• For Net Profit, as of Jun 2025, the value is 452.00 Cr.. The value appears strong and on an upward trend. It has increased from 412.00 Cr. (Mar 2025) to 452.00 Cr., marking an increase of 40.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.42. The value appears strong and on an upward trend. It has increased from 4.03 (Mar 2025) to 4.42, marking an increase of 0.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:19 am

Growth

Last Updated: September 5, 2025, 5:05 am

Balance Sheet

Last Updated: November 9, 2025, 2:05 pm

Below is a detailed analysis of the balance sheet data for Godrej Consumer Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 102.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 102.00 Cr..
• For Reserves, as of Sep 2025, the value is 12,061.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,897.00 Cr. (Mar 2025) to 12,061.00 Cr., marking an increase of 164.00 Cr..
• For Borrowings, as of Sep 2025, the value is 4,113.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4,009.00 Cr. (Mar 2025) to 4,113.00 Cr., marking an increase of 104.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 3,624.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,289.00 Cr. (Mar 2025) to 3,624.00 Cr., marking an increase of 335.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 19,901.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,298.00 Cr. (Mar 2025) to 19,901.00 Cr., marking an increase of 603.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 11,248.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,676.00 Cr. (Mar 2025) to 11,248.00 Cr., marking an increase of 572.00 Cr..
• For CWIP, as of Sep 2025, the value is 406.00 Cr.. The value appears to be declining and may need further review. It has decreased from 464.00 Cr. (Mar 2025) to 406.00 Cr., marking a decrease of 58.00 Cr..
• For Investments, as of Sep 2025, the value is 2,325.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,645.00 Cr. (Mar 2025) to 2,325.00 Cr., marking a decrease of 1,320.00 Cr..
• For Other Assets, as of Sep 2025, the value is 5,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,513.00 Cr. (Mar 2025) to 5,922.00 Cr., marking an increase of 1,409.00 Cr..
• For Total Assets, as of Sep 2025, the value is 19,901.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,298.00 Cr. (Mar 2025) to 19,901.00 Cr., marking an increase of 603.00 Cr..

Notably, the Reserves (12,061.00 Cr.) exceed the Borrowings (4,113.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Godrej Consumer Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 18.11. This value is within the healthy range. It has increased from -5.48 (Mar 24) to 18.11, marking an increase of 23.59.
• For Diluted EPS (Rs.), as of Mar 25, the value is 18.11. This value is within the healthy range. It has increased from -5.48 (Mar 24) to 18.11, marking an increase of 23.59.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from -3.12 (Mar 24) to 20.39, marking an increase of 23.51.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 117.34. It has decreased from 123.18 (Mar 24) to 117.34, marking a decrease of 5.84.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 117.34. It has decreased from 123.18 (Mar 24) to 117.34, marking a decrease of 5.84.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 140.41. It has increased from 137.82 (Mar 24) to 140.41, marking an increase of 2.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 32.45. This value is within the healthy range. It has increased from 31.41 (Mar 24) to 32.45, marking an increase of 1.04.
• For PBIT / Share (Rs.), as of Mar 25, the value is 30.16. This value is within the healthy range. It has increased from 29.05 (Mar 24) to 30.16, marking an increase of 1.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 26.12. This value is within the healthy range. It has increased from 1.94 (Mar 24) to 26.12, marking an increase of 24.18.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 18.11. This value is within the healthy range. It has increased from -5.48 (Mar 24) to 18.11, marking an increase of 23.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.11. This value is within the healthy range. It has increased from -5.48 (Mar 24) to 18.11, marking an increase of 23.59.
• For PBDIT Margin (%), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 22.78 (Mar 24) to 23.10, marking an increase of 0.32.
• For PBIT Margin (%), as of Mar 25, the value is 21.47. This value exceeds the healthy maximum of 20. It has increased from 21.08 (Mar 24) to 21.47, marking an increase of 0.39.
• For PBT Margin (%), as of Mar 25, the value is 18.60. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 18.60, marking an increase of 17.20.
• For Net Profit Margin (%), as of Mar 25, the value is 12.89. This value exceeds the healthy maximum of 10. It has increased from -3.97 (Mar 24) to 12.89, marking an increase of 16.86.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.89. This value is within the healthy range. It has increased from -3.97 (Mar 24) to 12.89, marking an increase of 16.86.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.43. This value is within the healthy range. It has increased from -4.44 (Mar 24) to 15.43, marking an increase of 19.87.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.21. This value is within the healthy range. It has increased from 23.02 (Mar 24) to 24.21, marking an increase of 1.19.
• For Return On Assets (%), as of Mar 25, the value is 9.41. This value is within the healthy range. It has increased from -3.03 (Mar 24) to 9.41, marking an increase of 12.44.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.32, marking an increase of 0.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.75. It has decreased from 0.78 (Mar 24) to 0.75, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has increased from 0.99 (Mar 24) to 1.06, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.76 (Mar 24) to 0.85, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.68. This value exceeds the healthy maximum of 8. It has increased from 4.04 (Mar 24) to 10.68, marking an increase of 6.64.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 138.05. This value exceeds the healthy maximum of 50. It has increased from -91.23 (Mar 24) to 138.05, marking an increase of 229.28.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 122.57. This value exceeds the healthy maximum of 50. It has increased from -160.02 (Mar 24) to 122.57, marking an increase of 282.59.
• For Earning Retention Ratio (%), as of Mar 25, the value is -38.05. This value is below the healthy minimum of 40. It has decreased from 191.23 (Mar 24) to -38.05, marking a decrease of 229.28.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is -22.57. This value is below the healthy minimum of 40. It has decreased from 260.02 (Mar 24) to -22.57, marking a decrease of 282.59.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.48. This value is within the healthy range. It has decreased from 10.84 (Mar 24) to 9.48, marking a decrease of 1.36.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.47. This value is within the healthy range. It has decreased from 7.47 (Mar 24) to 6.47, marking a decrease of 1.00.
• For Enterprise Value (Cr.), as of Mar 25, the value is 121,934.54. It has decreased from 130,631.58 (Mar 24) to 121,934.54, marking a decrease of 8,697.04.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.49. This value exceeds the healthy maximum of 3. It has decreased from 9.27 (Mar 24) to 8.49, marking a decrease of 0.78.
• For EV / EBITDA (X), as of Mar 25, the value is 36.74. This value exceeds the healthy maximum of 15. It has decreased from 40.66 (Mar 24) to 36.74, marking a decrease of 3.92.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.25. This value exceeds the healthy maximum of 3. It has decreased from 9.08 (Mar 24) to 8.25, marking a decrease of 0.83.
• For Retention Ratios (%), as of Mar 25, the value is -38.05. This value is below the healthy minimum of 30. It has decreased from 191.23 (Mar 24) to -38.05, marking a decrease of 229.28.
• For Price / BV (X), as of Mar 25, the value is 9.87. This value exceeds the healthy maximum of 3. It has decreased from 10.16 (Mar 24) to 9.87, marking a decrease of 0.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.25. This value exceeds the healthy maximum of 3. It has decreased from 9.08 (Mar 24) to 8.25, marking a decrease of 0.83.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness